Area of research
Rheumatology · Hematology
Research interest
Research interests include Folate and B Vitamins Research, Iron Metabolism and Disorders, Metabolism and Genetic Disorders, and Hemoglobinopathies and Related Disorders.
Fortification, folate and vitamin B12 balance, and the nervous system. Is folic acid excess potentially harmful?
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency
Biology of Anemia: A Public Health Perspective
Approaches to Address the Anemia Challenge
Mandatory food fortification with folic acid
Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case–control analysis from the UK Biobank
Associations between Genetic Variants and Blood Biomarkers of One-Carbon Metabolism in Postmenopausal Women from the Women's Health Initiative Observational Study.
Associations between Genetic Variants and Blood Biomarkers of One-Carbon Metabolism in Postmenopausal Women from the Women's Health Initiative Observational Study
Knowledge gaps in understanding the metabolic and clinical effects of excess folates/folic acid: a summary, and perspectives, from an NIH workshop
Valproate and folate: Congenital and developmental risks
Blueprint for a pop-up SARS-CoV-2 testing lab
Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease
Correction: Vitamin B12 deficiency
Folate‐mediated one‐carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: <scp>W</scp>omen's <scp>H</scp>ealth <scp>I</scp>nitiative <scp>O</scp>bservational <scp>S</scp>tudy
Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study
Plasma Choline Metabolites and Colorectal Cancer Risk in the Women's Health Initiative Observational Study
Interleukin-6, Age, and Corpus Callosum Integrity
Biomarkers of One-Carbon Metabolism Are Associated with Biomarkers of Inflammation in Women
Homocysteine, cysteine, and risk of incident colorectal cancer in the Women’s Health Initiative observational cohort